ACTR-68. CONCORDANCE OF EGFR AND MGMT ANALYSES BETWEEN LOCAL AND CENTRAL LABORATORIES: IMPLICATIONS FOR CLINICAL TRIAL DESIGN AND PRECISION MEDICINE FOR DEPATUXIZUMAB-MAFODOTIN (ABT-414) IN GLIOBLASTOMA (GBM)
暂无分享,去创建一个
W. Curran | M. Mehta | P. Canoll | M. Mansukhani | A. Lassman | P. Ansell | V. Murty | E. Bain | K. Holen | C. Dimino | James Lee | L. Roberts-Rapp